Source:http://linkedlifedata.com/resource/pubmed/id/17391375
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-3-29
|
pubmed:abstractText |
Until recently, most reported cases of bacteraemia caused by multidrug-resistant strains of Enterobacteriacae producing an extended-spectrum beta-lactamase (ESBL) in Europe have been nosocomial in origin. However, increasing numbers of reports of community-acquired bacteraemia and urinary tract infection caused by ESBL-producing microorganisms suggest that the geographical origin of patients should be taken into account as a risk-factor for possible ESBL production. Early identification of patients at high-risk of infection with ESBL-producing microorganisms, based on their geographical origin and travel history, should help to optimise initial antibiotic treatment strategies for severe urinary tract infections in Europe.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1198-743X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
219-21
|
pubmed:meshHeading |
pubmed-meshheading:17391375-Anti-Bacterial Agents,
pubmed-meshheading:17391375-Drug Resistance, Bacterial,
pubmed-meshheading:17391375-Enterobacteriaceae,
pubmed-meshheading:17391375-Europe,
pubmed-meshheading:17391375-Humans,
pubmed-meshheading:17391375-Urinary Tract Infections,
pubmed-meshheading:17391375-beta-Lactamases
|
pubmed:year |
2007
|
pubmed:articleTitle |
Is it time to reconsider initial antibiotic treatment strategies for severe urinary tract infections in Europe?
|
pubmed:publicationType |
Editorial
|